TrialJournal of Crohn's & colitis2026

2'-Fucosyllactose modulates gut microbiota and systemic metabolism in mild-to-moderate ulcerative colitis: a randomized crossover trial.

James M Kennedy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.